(MedPage Today) — The FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, maker Lenz Therapeutics announced on Thursday.
It marks the first aceclidine-based solution to be approved…
Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/116795
Author :
Publish date : 2025-08-01 19:37:00
Copyright for syndicated content belongs to the linked Source.
